ID: ALA3335714

Max Phase: Preclinical

Molecular Formula: C6H6OSe

Molecular Weight: 173.07

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O[Se]c1ccccc1

Standard InChI:  InChI=1S/C6H6OSe/c7-8-6-4-2-1-3-5-6/h1-5,7H

Standard InChI Key:  KUVIBICSCQYQOE-UHFFFAOYSA-N

Associated Targets(Human)

Gamma-butyrobetaine dioxygenase 162 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 173.07Molecular Weight (Monoisotopic): 173.9584AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Rydzik AM, Brem J, Struwe WB, Kochan GT, Benesch JL, Schofield CJ..  (2014)  Ejection of structural zinc leads to inhibition of γ-butyrobetaine hydroxylase.,  24  (21): [PMID:25266780] [10.1016/j.bmcl.2014.09.035]

Source